Study Reveals COVID-19 Vaccines May Help Strengthen Cancer Treatment
The study also found that cancer patients who received COVID-19 mRNA vaccines
WASHINGTON — In a groundbreaking discovery, U.S. scientists have found that COVID-19 mRNA vaccines may aid in cancer treatment by strengthening the body’s immune system, according to new research.
The study, reported by CNN, revealed that mRNA vaccines — originally developed to prevent COVID-19 — could also benefit cancer patients by boosting their immune response and enhancing the effectiveness of modern cancer therapies.
Researchers said the vaccines do not directly reduce or eliminate cancer but activate the immune system, helping the body fight tumors more effectively. The activation works like an “alarm system,” alerting the immune defenses to respond aggressively against cancer cells throughout the body.
Read more: Are young people dying of Heart Attacks after getting COVID vaccine during pandemic?
The study also found that cancer patients who received COVID-19 mRNA vaccines, such as Pfizer or Moderna, within the first 100 days of treatment had nearly double the survival rate after three years compared to those who did not.
Experts noted that the vaccines were particularly beneficial for patients with advanced lung or skin cancers (melanoma), significantly improving their chances of long-term survival.
According to the researchers, the vaccine’s benefit is not linked to preventing cancer-causing infections but to the mRNA technology itself, which activates immune cells and helps them attack cancer cells. Rather than targeting specific tumors, the vaccine strengthens the immune system overall, making it more capable of weakening and controlling cancer growth.
Comments are closed, but trackbacks and pingbacks are open.